CHP II LP 3
3 · ALNYLAM PHARMACEUTICALS INC · Filed Jun 1, 2004
Insider Transaction Report
Form 3
CHP II LP
10% Owner
Holdings
Series A Convertible Preferred Stock
→ Common Stock (526,315 underlying)Series B Convertible Preferred Stock
→ Common Stock (1,284,210 underlying)Series C Convertible Preferred Stock
→ Common Stock (48,843 underlying)
Footnotes (3)
- [F1]Automatically converts into common stock upon the closing of the issuer's initial public offering of common stock.
- [F2]N/A
- [F3]Reflects a 1-for-1.9 reverse stock split, which became effective on May 7, 2004, pursuant to which each share of Series A, B and C Preferred Stock will automatically convert into approximately 0.53 shares of common stock upon the closing of the issuer's initial public offering of common stock.